lncRNA in the liver: Prospects for fundamental research and therapy by RNA interference

被引:38
作者
Smekalova, Elena M. [1 ]
Kotelevtsev, Yuri V. [2 ]
Leboeuf, Dominique [2 ]
Shcherbinina, Evgeniya Y. [2 ]
Fefilova, Anna S. [2 ]
Zatsepin, Timofei S. [2 ,3 ,4 ]
Koteliansky, Victor [2 ,3 ]
机构
[1] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA
[2] Skolkovo Inst Sci & Technol, 4 Alfred Nobel St, Skolkovo 143025, Russia
[3] Lomonosov Moscow State Univ, Dept Chem, Leninskie Gory 1-3, Moscow 119992, Russia
[4] Cent Res Inst Epidemiol, Novogireevskaya 3a, Moscow 111123, Russia
基金
俄罗斯科学基金会;
关键词
Long noncoding RNA (lncRNA); Delivery; siRNA; Liver; GalNAc conjugate; Lipid nanoparticle (LNP); Endosome escape; RNAi; Hepatocellular carcinoma; LONG NONCODING RNA; IN-VIVO DELIVERY; HEPATOCELLULAR-CARCINOMA METASTASIS; APTAMER-SIRNA CHIMERAS; ASIALOGLYCOPROTEIN RECEPTOR; LIPID NANOPARTICLES; GENE-EXPRESSION; CELLULAR UPTAKE; ANTISENSE OLIGONUCLEOTIDES; INTRACELLULAR TRAFFICKING;
D O I
10.1016/j.biochi.2016.06.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Long non-coding RNAs constitute the most abundant part of the transcribed mammalian genome. lncRNAs affect all essential processes in the living cell including transcription, splicing, translation, replication, shaping of chromatin and post translational modification of proteins. Alterations in lncRNA expression have been linked to a number of diseases; thus, modulation of lncRNA expression holds a huge potential for gene-based therapy. In this review we summarize published data about lncRNAs in the context of hepatic carcinogenesis and liver fibrosis, and the corresponding potential targets for gene therapy. Recent advancements in targeted delivery to the liver made RNA interference an invaluable tool to decipher hepatic lncRNA function and to develop lncRNA-oriented therapies for liver-involved diseases in the future. Different approaches for RNA delivery that can be used for functional studies in the lab and for clinical lncRNA based applications are critically discussed in this review. Published by Elsevier B.V.
引用
收藏
页码:159 / 172
页数:14
相关论文
共 182 条
[11]  
Berasain Carmen, 2011, Cancers (Basel), V3, P2444, DOI 10.3390/cancers3022444
[12]   Delivery of therapeutic oligonucleotides with cell penetrating peptides [J].
Boisguerin, Prisca ;
Deshayes, Sebastien ;
Gait, Michael J. ;
O'Donovan, Liz ;
Godfrey, Caroline ;
Betts, Corinne A. ;
Wood, Matthew J. A. ;
Lebleu, Bernard .
ADVANCED DRUG DELIVERY REVIEWS, 2015, 87 :52-67
[13]   Viral vectors: from virology to transgene expression [J].
Bouard, D. ;
Alazard-Dany, N. ;
Cosset, F-L .
BRITISH JOURNAL OF PHARMACOLOGY, 2009, 157 (02) :153-165
[14]   Dimeric DNA Aptamer Complexes for High-capacity-targeted Drug Delivery Using pH-sensitive Covalent Linkages [J].
Boyacioglu, Olcay ;
Stuart, Christopher H. ;
Kulik, George ;
Gmeiner, William H. .
MOLECULAR THERAPY-NUCLEIC ACIDS, 2013, 2 :e107
[15]   RNA interference in mammalian cells by chemically-modified RNA [J].
Braasch, DA ;
Jensen, S ;
Liu, YH ;
Kaur, K ;
Arar, K ;
White, MA ;
Corey, DR .
BIOCHEMISTRY, 2003, 42 (26) :7967-7975
[16]   microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer [J].
Braconi, C. ;
Kogure, T. ;
Valeri, N. ;
Huang, N. ;
Nuovo, G. ;
Costinean, S. ;
Negrini, M. ;
Miotto, E. ;
Croce, C. M. ;
Patel, T. .
ONCOGENE, 2011, 30 (47) :4750-4756
[17]  
Braconi C, 2012, CURR CANCER DRUG TAR, V12, P1073
[18]   Investigation of enzyme-sensitive lipid nanoparticles for delivery of siRNA to blood-brain barrier and glioma cells [J].
Bruun, Jonas ;
Larsen, Trine B. ;
Jolck, Rasmus I. ;
Eliasen, Rasmus ;
Holm, Rene ;
Gjetting, Torben ;
Andresen, Thomas L. .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2015, 10 :5995-6008
[19]   DNA Aptamer Based Nanodrugs: Molecular Engineering for Efficiency [J].
Cansiz, Sena ;
Zhang, Liqin ;
Wu, Cuichen ;
Wu, Yuan ;
Teng, I-Ting ;
Hou, Weijia ;
Wang, Yanyue ;
Wan, Shuo ;
Cai, Ren ;
Jin, Chen ;
Liu, Qiaoling ;
Tan, Weihong .
CHEMISTRY-AN ASIAN JOURNAL, 2015, 10 (10) :2084-2094
[20]   Cytoplasmic long noncoding RNAs are frequently bound to and degraded at ribosomes in human cells [J].
Carlevaro-Fita, Joana ;
Rahim, Anisa ;
Guigo, Roderic ;
Vardy, Leah A. ;
Johnson, Rory .
RNA, 2016, 22 (06) :867-882